跳至主要内容
临床试验/CTRI/2024/07/069766
CTRI/2024/07/069766尚未招募3 期

Clinical efficacy of oral Quetiapine as an adjuvant to standard of care in patients with alcohol withdrawal state with delirium- an open-label parallel group clinical study. - NI

Dr Jeel Vasa0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age between 18 to 60 years
  • Patients of either gender
  • Patients with alcohol dependance suffering alcohol withdrawal in delirium (ICD 10 criteria F10.4)

排除标准

  • Ages less than 18 years, or more than 60 years.
  • Patients with comorbid intellectual disability, history of psychosis, dementia
  • Patients with symptoms of Wernicke’s encephalopathy showing ophthalmoplegia, ataxia on clinical examination
  • Patients with a QTc interval above 500 msecs
  • Patient with recent (less than 3 months) cardiac events
  • Patients with prior allergic reactions to Quetiapine
  • Patients with a history of extrapyramidal symptoms with use of Quetiapine.
  • Patients with suspected multifactorial causes for the onset of delirium

研究者

发起方
Dr Jeel Vasa

相似试验